Recros Medica, Inc. today announced positive 90-day results from its CONFORM study assessing the efficacy, safety and patient satisfaction of Rotational Fractional Resection (RFR) procedure for submental contouring.
About aircan1This author has not yet filled in any details.
So far aircan1 has created 11 blog entries.
Recros Medica, Inc. announced today that its de novo regulatory submission for the Nuvellus™ Focal Contouring System has been accepted for review by the US Food and Drug Administration (FDA). Nuvellus™, which utilizes the company’s proprietary Rotational Fractional Resection (RFR) technology, may provide medical aesthetic physicians a minimally-invasive single treatment option to improve submental (neck and jowl) contouring.
A new technology offers a fresh approach to treatment of submental contouring.
The Nuvellus Focal Contouring System, incorporating the Rotational Fractional Resection (RFR) technology in development by Recros Medica Inc, may fill that gap.
A promising new minimally invasive procedure for skin contouring.
Efficacy, Safety, and Subject Satisfaction Using Rotational Fractional Resection for Read more
SAN DIEGO, Oct. 9, 2018 /PRNewswire/ — Recros Medica, Inc. Read more
SAN DIEGO, CA, September 27, 2018 – Recros Medica, Inc., Read more
SAN DIEGO, June 19, 2018 /PRNewswire/ — Recros Read more
SAN DIEGO, CA, January 4, 2018 – Recros Medica, Inc., Read more